Company news
Sanara Medtech Inc. (NASDAQ:SMTI) news
Sanara Medtech Inc. news releases on 6ix. Latest, Aug 3, 2026: Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price…
Press releases & updates
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
August 3, 2026
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
May 11, 2026
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
April 13, 2026
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance
March 23, 2026
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds
March 10, 2026
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
March 3, 2026
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd
February 17, 2026
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance
January 23, 2026
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution
January 7, 2026
Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™
December 10, 2025
Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd
November 19, 2025
Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited)
November 12, 2025
Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business
November 11, 2025
Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025
October 1, 2025
Sanara MedTech Inc. Announces Chief Executive Officer Transition
September 2, 2025
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
August 27, 2025
Sanara MedTech Inc. Reports Second Quarter 2025 Financial Results
August 14, 2025
Sanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)
August 13, 2025
Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025
July 15, 2025
Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program
July 14, 2025
Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)
May 14, 2025
Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025
April 23, 2025
Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
April 10, 2025
Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)
March 25, 2025
Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
March 11, 2025
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024
January 20, 2025
Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments
January 20, 2025
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
January 20, 2025
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th
November 24, 2024
Sanara MedTech Inc. Reports Third Quarter 2024 Results
November 11, 2024
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
October 30, 2024
Sanara MedTech Inc. Announces Changes to Its Board of Directors
October 6, 2024
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC
September 10, 2024
Sanara MedTech Inc. Announces Second Quarter 2024 Results
August 11, 2024
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates
July 29, 2024
Sanara MedTech Inc. Announces First Quarter 2024 Results
May 12, 2024
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
April 28, 2024
Sanara MedTech Inc. Announces $55 Million Debt Facility
April 17, 2024
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer
April 4, 2024
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
March 24, 2024
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
March 12, 2024
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
February 21, 2024
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
January 2, 2024
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing
November 29, 2023
Sanara MedTech Inc. Announces Third Quarter 2023 Results
November 12, 2023
Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product Updates
October 9, 2023
Sanara MedTech to Participate in Two Upcoming Conferences
September 11, 2023
Sanara MedTech Inc. Announces Second Quarter 2023 Results
August 13, 2023
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
August 1, 2023
Sanara MedTech Inc. Announces First Quarter 2023 Results
May 14, 2023